loc: It would have been nine to twelve months before covid when stock was waffling between $1.20 and .90 and everyone was concerned it would not be able to hold the $1 threshold for continuous 90 days. Also, It seems as though from other recent posts, covid is being advanced as excuses for unmet goals. A reputable company would come forward and lay those issues out for stockholders. GNBT has been silent.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links